Tag | Content |
---|
EnhancerAtlas ID | HS188-09222 |
Organism | Homo sapiens |
Tissue/cell | Th2 |
Coordinate | chr3:88080290-88081860 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
IRF1 | MA0050.2 | chr3:88081102-88081123 | TTTCACTTTCAGTTTCTCAGA | + | 6.21 | IRF1 | MA0050.2 | chr3:88081096-88081117 | AATTAGTTTCACTTTCAGTTT | + | 9.51 | IRF2 | MA0051.1 | chr3:88081095-88081113 | CAATTAGTTTCACTTTCA | - | 6.27 | IRF8 | MA0652.1 | chr3:88081100-88081114 | AGTTTCACTTTCAG | - | 6.19 | NFAT5 | MA0606.1 | chr3:88080491-88080501 | ATTTTCCATT | + | 6.02 | NFATC1 | MA0624.1 | chr3:88080491-88080501 | ATTTTCCATT | + | 6.02 | NFATC3 | MA0625.1 | chr3:88080491-88080501 | ATTTTCCATT | + | 6.02 | TFAP4 | MA0691.1 | chr3:88081178-88081188 | ATCAGCTGTT | - | 6.02 |
|
| Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
SE_13872 | chr3:88079079-88082202 | CD34_Primary_RO01536 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH03I088031 | chr3 | 88080321 | 88082531 |
|
Enhancer Sequence | CACATTTTAA TGTTTTAATT CTCTTTTTTA CTTTAAAATA TTTTAATGAT CTTTAAAGTA 60 GCTGTACCTT AAGGCATTTT TAGATTAGTA TCTAAATGCT TATTTACTTA TGCTCCAACA 120 ACTGACTATC CTTAATGGAG ATATTGTTTA TCTCTGTTTT AGATACTTAC AGAACATAAC 180 AACCAAATTA TCTATTCATG CATTTTCCAT TGTATTGAAA CTGGTGATAG CTTTGTCTTA 240 AGCCAAACAT AGTTTTGTAC AGAAACAGAC ATACTTAAAT TTGGTGATCA ATTTTGGAAT 300 CCAGAGAGAA TAGAACTCTC CTTTATGCAA AAATAATTGT CCCAAAGAAA TCTTGGCTTC 360 AGAACCTCAA GTTATCAAGG CTGTCAGAGG TCTTATGATA GTCCATAAAA ACCATTTGCT 420 AAATAAATCA TTTGTGTTGA AACTATAATT TACATGATTT GGTATACTGG GAATATAGCT 480 GGTACTCAAG TAATACTTTT GAAGGAATGA AGAGCCCACA TATACAATTA TAGCATACCA 540 TTTTTATTTA AATAGCCTTC ATTGAACTCT TCTGTCTGGA ATAGTAATGG GAAAGTTCAG 600 GAGACAGGAG ATAGGGCCTG GAAGGTAGTG CAGATGGGGC TGAGTGTGAG TTTTGTCTAT 660 AAAAGGCCTC TGGCTGAGTA TGGGTGGGGA GGTTTTATAT GTCCTTGAAC ATGAGACTAG 720 GTGACTTTTA GAACAGTTGT AGATCAGATG TAAACATGCA TATGCATGCA TTCATGTTAT 780 TTCATAGGCT ATTGAGATTT TATTGCAATT AGTTTCACTT TCAGTTTCTC AGAGTGAAAG 840 GGTCTAGTTT GGCAGTGTTG CCTTAACGGG CACTGCAGCC TTACTGGCAT CAGCTGTTCA 900 ATTTAGCTCC CTTTAAACCT ATTTAACAAA GGACTAGCAT CCTATACCAA ACTTTTACAA 960 CCTTTTACCA AACCTTTTTC TGATCTGTGC CGATCAGAAG CTTTTGCTAA TTCTGCATGT 1020 TTAATTCACC TGGGGTTTTT TTGCCCAGGG TTTATTTGAC AATAATTTTC TTGTTCTCAG 1080 TATCTCCTCT CACTGTGATT TTCAGAACAT GATTTGGCTC CTGTCACACT CGGTGCTTTT 1140 GGGGAATCTC TCCTGTTGAG TTCTACATCT TAATAACTTC CCTAGATTTT GTGTTTTGTT 1200 CTTAGGGCAG CCGTGATGTA TAAATGAGCC CTTCCAATGC CTCAGTTGTT GAGCTATATG 1260 ATTTTACATA TATGATTCAA TTTCCAAATC CCTCTTTGAT CTGTGAGCTC CTCAAGGCCA 1320 GAGCTGTGAC TTATCCATCT TTGTATGTCC AGTATCTAGA TTACAGCCTG AAATGCTTCA 1380 GGCATTCAGT AATAGCTGAA ATGAACAGAA AGAGAAGCAG AATGGGACTT GAACTTGGAA 1440 GAAGTTTATT CTAATGACCA AATTTTTTCA TTCTATATGT CATATTTATT GCCAAGTTGT 1500 TTTATAGCAC TTTCTTTTCA TGTATACACT TGCTACCAAC CGCACAACAA AGTAGAAATT 1560 ACTATCCTCA 1570
|